Next generation
healthcare products

Developed to control the spread of infectious diseases and increase
their accessibility through decentralized manufacturing in
collaboration with local partners.

CE-Marked SARS-CoV-2 Total Ab ELISA

The BioMARIC SARS CoV-2 Total Ab ELISA is an Enzyme-Linked Immunosorbent Assay for the qualitative detection of Total Antibodies against SARS-CoV-2 virus in human serum and plasma samples.

Find out more

About BioMARIC

BioMARIC is a privately owned Belgian biotechnology company founded in 2001, predominantly focusing on prevention and control of infectious diseases.

BioMARIC continuously maintains global collaboration with the third world scientific and medical community on projects that target to slow down the spread of infectious diseases.

Healthcare products accessible globally at affordable prices

Create maximum synergy between different stakeholders to make high quality healthcare products accessible at affordable prices in ALL countries of the world, in particular the growing economy countries and the countries located in resource-poor parts of the world.

Depending on local market conditions, BioMARIC alliances can be based on several collaborative models:


Full Technology Transfer and supply of critical materials for local manufacturing at the partner’s facilities


Supply of selected critical detection modules developed for specific use in immunoassays


OEM manufacturing of the BioMARIC assay (kit) under the partner’s label

Become our distributor

We cooperate with our partners to find the best model for cooperation and create maximum synergy to the benefit of all parties involved, including the local community.

Contact us


In 2019, BioMARIC was awarded the EN ISO 13485:2016 certification, which ensures that our products and services meet the stringent quality standards through an effective quality management system.

Contact BioMARIC

Klaartestraat 16

9052 Gent

+32 (0) 9 242.94.94